San Diego Convention Center, San Diego, CA
Room 1AB
Please note: No additional fee is required to attend this CME/CPE activity; however, registration to AMCP's 27th Annual Meeting & Expo is required.
AMCP's 27th Annual Meeting & Expo
Click here to download the slides from this symposium
Hot Topics Include:
- Recent clinical data affecting evidence-based treatment guidelines for MM
- Comprehensive care strategies involving effective communication methods
- Innovative oncology pharmacy benefit models integrated with specialty pharmacy management services
Distinguished Faculty Presenters
|
David Frame, PharmD Hematology/Oncology and Bone Marrow Specialist University of Michigan Health System Assistant Professor of Pharmacy University of Michigan Assistant Professor of Pharmacology and Medicine Rush University |
|
James Kenney, Jr., RPh, MBA Manager, Specialty and Pharmacy Contracts Harvard Pilgrim Health Care |
|
David Vesole, MD, PhD, FACP Co-Chief and Director of Research, Multiple Myeloma John Theurer Cancer Center Hackensack University Medical Center |
Who Should Attend?
This activity is designed to meet the educational needs of managed care pharmacy directors, clinical pharmacists, quality directors, medical directors, members of AMCP, and other managed health care professionals attending AMCP's 27th Annual Meeting & Expo.
Statement of Need/Program Overview
As novel agents become available to treat multiple myeloma (MM), treatment decision making is becoming more complex. In light of new drug developments as well as expanding uses of current agents, managed care organizations (MCOs) and other payer organizations need to appropriately and effectively design benefits that optimize both cost-efficiency and patient outcomes. Emerging clinical and economic techniques, practical examples, and expert recommendations will be formulated to illuminate key learnings using MM as the therapeutic area of focus.
Educational Objectives
After completing this activity, the participant should be better able to:
- Evaluate recent clinical data affecting evidence-based treatment guidelines for MM
- Demonstrate the value of clinical pathways initiatives as a means of reducing treatment variability and improving clinical and economic outcomes in the management of MM
- Implement comprehensive care strategies involving effective communication methods and innovative oncology pharmacy benefit models integrated with specialty pharmacy management services
- Provide accurate and appropriate counsel as part of the managed care treatment team
Date and Time
Wednesday, April 8, 2015
6:15 AM - 8:00 AM PDT
San Diego Convention Center
Room 1AB
San Diego, CA
Agenda
| 6:15 AM | Breakfast and Registration |
| 6:30 AM | Pre-Activity Learning Assessment and Opening Comments |
| 6:35 AM |
An Update on Practice Guidelines in Multiple Myeloma Management:
Treatment Recommendations and Emerging Therapies
David Vesole, MD, PhD, FACP |
| 7:00 AM |
Designing and Implementing Clinical Pathways Initiatives to Reduce Treatment Variability and Improve Outcomes in Multiple Myeloma David Frame, PharmD |
| 7:20 AM |
Improving Multiple Myeloma Care via the Comprehensive Model: Attaining Provider Buy-in for Management Interventions and Specialty Pharmacy Services James Kenney, Jr., RPh, MBA |
| 7:45 AM | Audience Q&A Session |
| 7:55 AM |
Key Takeaways and Closing Comments Post-Activity Assessment and Evaluation |
Physician Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine and Impact Education, LLC. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation
Postgraduate Institute for Medicine designates this live activity for a maximum of 1.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 |
Pharmacist Accreditation Statement
Postgraduate Institute for Medicine is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. |
Credit Designation
Postgraduate Institute for Medicine designates this continuing education activity for 1.5 contact hours (0.15 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number - (0809-9999-15-049-L01-P)
For Pharmacists: Upon receipt of a completed activity evaluation form, you will receive an email from the Postgraduate Institute for Medicine within 3 weeks with a link and directions to submit your credit to the NABP CPE Monitor Service.
Type of Activity: Application
Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. The existence or absence of COI for everyone in a position to control content will be disclosed to participants prior to the start of each activity.
Americans with Disabilities Act
Event staff will be glad to assist you with any special needs (ie, physical, dietary, etc). Please contact Impact Education, LLC, prior to the live event at (215) 619-8812.
Fee Information
No additional fee is required to attend this CPE/CME activity.
Please note: No additional fee is required to attend this CME/CPE activity; however, registration to AMCP's 27th Annual Meeting & Expo is required.
Pre-registration will close at 12:00 pm on April 7, 2015.
Walk-in registration will be available at the time of the program.
If you have any questions, please call (215) 619-8812 or email info@impactedu.net.
Click here to pre-register for this symposium.